Omeprazol Ratiopharm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children.

GNH USA supplies Omeprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Ratiopharm is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Adverse reactions to omeprazole are generally mild to moderate and vary in frequency.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and flank pain.

When using Omeprazol Ratiopharm, consider the following precautions: - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate liver health: use cautiously in hepatic disease. - Monitor long‑term therapy: periodic assessment for bone health and magnesium levels. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines; monitoring is recommended.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising HIV treatment efficacy. - Warfarin: enhanced anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Phenytoin: decreased serum levels, potentially reducing seizure control. - Digoxin: increased serum concentration, risking toxicity. - Methotrexate: higher systemic exposure, especially at high doses. - Iron supplements: reduced absorption, may require timing adjustments.